The second edition of Elets Diagnostics Leadership Summit will create a virtual networking-cum-knowledge platform to explore adoption of new-age technologies and best practices, investment opportunities, and evaluate policies for transforming the diagnostics industry.
The Indian diagnostics industry emerged as the backbone of the Covid-19 management. It will gain more prominence in the light of greater realisation to prepare for the possible third wave of the Covid-19 and future pandemics. Elets Technomedia Pvt Ltd along with its flagship eHEALTH is set to organise the second edition of the Elets Diagnostics Leadership Summit on 23 – 24 September 2021 on a Virtual 3D platform – Avtaar.
With the theme, ‘Creating a Future Perfect Diagnostics Sector’, the two-day Summit will be a virtual networking-cum-knowledge platform to deliberate on digital technologies and innovations, investment opportunities, latest government policies and schemes, and best practices for transforming the diagnostics industry.
This Summit will be held after successfully organising the first edition of the Elets Diagnostics Leadership Summit on February 19 – 20 2021 virtually, which witnessed over 500 delegates, more than 70 speakers and 12 thought-provoking sessions and panel discussions.
Participants for the second edition of Elets Diagnostics Leadership Summit will be Policy Makers from Government Departments; MDs, CEOs, Promoters of Diagnostic Centre (Single Centre & Multiple Chain); MDs & CEOs of Genomics Test Labs; HoDs of Clinical Laboratories of Hospitals; Scientists, Technician & Technologists of Labs; Technology Providers; and Academicians.
Scientific Advisory Committee Member for the Summit are Dr Ravi Gaur, Principal Advisor Spice Health (Spice Jet Promoters Venture) and Founder, Dr G Path Labs, Co-Chair, CII Delhi Chapter Health Committee; Dr Avinash Phadke, Founder, SRL Phadke Labs; and N Venkateswaran, CEO, National Accreditation Board for Testing and Calibration Laboratories (NABL).
Plus, confirmed Key Speakers are Dr Arjun Dang, CEO, Dr Dang’s Lab; Dr Srinivas Chakravarthy N, Vice President, Technical HLA, TI Lab and Head, Laboratory, SRL Diagnostics and Fortis Hospital; Dr Barnali Das, Consultant Laboratory Medicine, Kokilaben Dhirubhai Ambani Hospital, Executive Member, IFCC Scientific Division, Chair, AACC India Section, CAP Inspector, and NABL Assessor; Group Captain (Retd) Dr (Prof ) Renu Madan, HoD, Pathology and Lab Medicine, Venkateshwar Hospital; Sanjeev Vashishta, Managing Director & CEO, PathKind Diagnostics Pvt Ltd; Prof Ashok Rattan, Advisor, Pathkind Laboratories; Dr Maithili Kavathekar, Director Laboratory Services, Sahyadri Speciality Hospital; Dr Anjali Tiwari, Lab Director and Technical Manager, Regency Hospital Ltd, Kanpur; Sukrut Jobanputra, CEO & Executive Director, Labassure; Dr Anita S. Bhaduri, President, IAP-Indian Division, Histopathologist & HoD, Lab Medicine, PD Hinduja Hospital & MRC; Dr (Col) Jyoti Kotwal, Senior Consultant & Head, Department of Hematology, Sir Ganga Ram Hospital; Dr Vineeta Sood, Lab Director, Department of Lab Medicine, Alchemist Hospital; Dr Rinu Goyal, Consultant Pathologist & Head, Laboratory, Sitaram Bhartia Institute of Science and Research; Dr Sunita Deshmukh, HoD, Lab Sciences & Blood Bank, Paras Hospitals; Dr Varsha Vadera, Consultant and Head Laboratory Medicine & Advanced Diagnostics, Kokilaben Dhirubhai Ambani Hospital; Dr Anil Handoo, Senior Director Hospital Laboratory Services, BLK Super Speciality Hospital; Dr Amrit Kaur Kaler, Professor of Pathology, TOMCH, Fellow (Molecular pathology & Cancer Genomics), Strand Life Sciences, HCG Bangalore; Dr (Col) Prabal Deb, Head of Operations (India), Aster Labs, and Lab Director, Aster Reference Lab, Bengaluru.
The speaker line-up is growing almost every day.
The second edition of Elets Diagnostics Leadership Summit will bring together the Indian diagnostics community and discuss varied pertinent issues, including Production Linked Incentive Scheme (PLI) for ‘Make in India’ of In-vitro diagnostics (IVD) and its raw materials: Scope and Challenges; How the diagnostic segment is gearing up for the possible third wave of the Covid-19 pandemic; The state of the Indian diagnostics industry: Outlook, Investment Scenario and Growth Opportunities; Diagnostics 4.0: The future of diagnostics labs in the digital era; Advanced Diagnostics for Infectious Disease: New testing platforms, technologies, and solutions; Diagnostics tools in Telehealth during the pandemic; Harmonising quality, cost and regulations for proliferating essential diagnostics during the pandemic; and Role of CBC and ESR helping in Chronic Disease Management, among others.
Besides, Elets Diagnostics Leadership Awards will be held on 23 September 2021, to celebrate the greatest achievements and innovations in the diagnostics segment. This Awards function invites nominations from professionals of the diagnostics community, including Diagnostics Associations, Diagnostics Centres and Chains, Clinical Laboratories of Hospitals, Genomics Test Labs, and Diagnostic Professionals.
NABL is a Supporting Partner and CrelioHealth is a Partner for the second edition of Elets Diagnostics Leadership Summit.
Don’t miss this Summit; Register now: https://diagnostics.eletsonline.com/